Oncimmune distributor inks sales agreement in Spain

Writer,

Archived article

Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.

Immunodiagnostics group Oncimmune Holdings said that its existing distributor in Spain and Portugal had signed an agreement with Spanish private healthcare company Vithas Group.

The agreement would see the distributor Sabartech sell the company's EarlyCDT Lung product as a screening test for early detection of lung cancer.

In addition, Vithas's laboratory was also promoting the test across Spain to further increase awareness of EarlyCDT Lung.

'This is the latest in a series of commercial agreements to increase the reach of EarlyCDT Lung in large European and North American healthcare markets and validate the product's increasing acceptance within major healthcare systems,' the company said.